| 1.64 -0.06 (-3.53%) | 03-02 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.03 | 1-year : | 2.37 |
| Resists | First : | 1.74 | Second : | 2.03 |
| Pivot price | 1.63  |
|||
| Supports | First : | 1.54 | Second : | 1.41 |
| MAs | MA(5) : | 1.64 |
MA(20) : | 1.63 |
| MA(100) : | 1.77 |
MA(250) : | 2.66 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 77.2 |
D(3) : | 74.1 |
| RSI | RSI(14): 49 |
|||
| 52-week | High : | 73.75 | Low : | 1.13 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BON ] has closed below upper band by 42.9%. Bollinger Bands are 49.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.7 - 1.71 | 1.71 - 1.72 |
| Low: | 1.59 - 1.6 | 1.6 - 1.61 |
| Close: | 1.63 - 1.64 | 1.64 - 1.65 |
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Mon, 02 Mar 2026
BON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Thu, 19 Feb 2026
Bon Natural Life Limited Announces Development of Apple Bio-Electronic Mask - marketscreener.com
Thu, 19 Feb 2026
AI-powered apple face mask aims at $100B anti-aging beauty boom - Stock Titan
Tue, 17 Feb 2026
Bon Natural Life Deepens AI-Driven Biomanufacturing Push With Chang’an Pilot Joint Lab - TipRanks
Tue, 17 Feb 2026
How Bon's new AI lab aims to grow greener ingredients for food and skincare - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 6 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 1.3 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 31 (K) |
| Shares Short P.Month | 32 (K) |
| EPS | -0.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.32 |
| Profit Margin | -10.7 % |
| Operating Margin | -17.8 % |
| Return on Assets (ttm) | -1.4 % |
| Return on Equity (ttm) | -4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.63 |
| Sales Per Share | 3.06 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -2.28 |
| PEG Ratio | 0 |
| Price to Book value | 0.17 |
| Price to Sales | 0.53 |
| Price to Cash Flow | 70.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|